188 related articles for article (PubMed ID: 31668943)
1. Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets.
Dong W; Wu P; Zhou D; Huang J; Qin M; Yang X; Wan M; Zong Y
Ultrasound Med Biol; 2020 Jan; 46(1):90-107. PubMed ID: 31668943
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy.
Guo H; Xu M; Cao Z; Li W; Chen L; Xie X; Wang W; Liu J
Mol Pharm; 2020 Feb; 17(2):541-553. PubMed ID: 31876426
[TBL] [Abstract][Full Text] [Related]
3. Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy.
Dong W; Wu P; Qin M; Guo S; Liu H; Yang X; He W; Bouakaz A; Wan M; Zong Y
Mol Pharm; 2020 Aug; 17(8):2891-2910. PubMed ID: 32678617
[TBL] [Abstract][Full Text] [Related]
4. Plasmid-loadable magnetic/ultrasound-responsive nanodroplets with a SPIO-NP dispersed perfluoropentane core and lipid shell for tumor-targeted intracellular plasmid delivery.
Dong W; Huang A; Huang J; Wu P; Guo S; Liu H; Qin M; Yang X; Zhang B; Wan M; Zong Y
Biomater Sci; 2020 Oct; 8(19):5329-5345. PubMed ID: 32793943
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma.
Chowdhury SM; Lee T; Bachawal SV; Devulapally R; Abou-Elkacem L; Yeung TA; Wischhusen J; Tian L; Dahl J; Paulmurugan R; Willmann JK
J Control Release; 2018 Jul; 281():19-28. PubMed ID: 29758233
[TBL] [Abstract][Full Text] [Related]
7. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
9. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
12. Sonoporation based on repeated vaporization of gold nanodroplets.
Liu WW; Ko HC; Li PC
Med Phys; 2022 Apr; 49(4):2761-2773. PubMed ID: 35172015
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo.
Wischhusen JC; Chowdhury SM; Lee T; Wang H; Bachawal S; Devulapally R; Afjei R; Sukumar UK; Paulmurugan R
J Control Release; 2020 May; 321():272-284. PubMed ID: 32004588
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-regulated non-viral vectors with improved tumor specificity in an orthotopic rat model of hepatocellular carcinoma.
Ronald JA; Katzenberg R; Nielsen CH; Jae HJ; Hofmann LV; Gambhir SS
Gene Ther; 2013 Oct; 20(10):1006-13. PubMed ID: 23719066
[TBL] [Abstract][Full Text] [Related]
17. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
[TBL] [Abstract][Full Text] [Related]
18. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
[TBL] [Abstract][Full Text] [Related]
19. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
